GSK Investigational Site
Oberhausen, North Rhine-Westphalia 46145
0 studies enrolling now · 4 studies all time
What they study most
Atherosclerosis, Hepatitis C, Chronic, Lung Cancer, Non-Small Cell, Neoplasms, Prostate
Studies at this site
- GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer — Stopped early
- Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes — Completed
- "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed
- Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease — Completed